Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative hydrocortisone to prevent atrial fibrillation after mitral valve surgery
2007-007085-38Phase 4Terminated
- Sponsor
- Kuopio University Hospital
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydrocortisone in mitral regurgitation (MR), aortic stenosis (AS) and Atrial fibrillation (AFib), sponsored by Kuopio University Hospital. Primary endpoint: Incidence of postoperative atrial fibrillation after mitral valve surgery. Started Jan 2008; status: terminated.
02
Drugs
hydrocortisone
03
Conditions
mitral regurgitation (MR)aortic stenosis (AS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2007-007085-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007085-38.